United States · 
Who invested in Carmot Therapeutics?
Carmot Therapeutics's investors include The Column Group.
20112012
$1.5MVenture$500KVenture
United States · Venture startup
Who invested in Carmot Therapeutics
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Carmot Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$2.1Mraised across 2 rounds since 2010, from 2 sources
$1.5MVenture$500KVenture
- Latest round
- Venture, $500KJul 2012
- Biggest round
- $1.5MVenture · Apr 2010
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $1.5M Apr 2010
- Biggest round
- $1.5M Venture · Apr 2010
- Between rounds
- 2.3 years from the last two
The rounds
- Jul 2012
- Apr 2010Venture$1.5M
No investor was named in the report.
Reported by sec.govSEC filing: $1.5M sold, first sale Apr 2010
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Carmot Therapeutics
How much has Carmot Therapeutics raised?
Carmot Therapeutics has raised $2.1M across 2 rounds since 2010.
When did Carmot Therapeutics last raise?
Carmot Therapeutics's most recent round was a Venture of $500K in Jul 2012.
What was Carmot Therapeutics's biggest round?
Carmot Therapeutics's largest round on record is $1.5M (Venture), in Apr 2010.
Who backed Carmot Therapeutics first?
Carmot Therapeutics's first round on record, in Jul 2012, was backed by The Column Group.
What stage is Carmot Therapeutics at?
Carmot Therapeutics's latest named round is a Venture, in Jul 2012.
Where is Carmot Therapeutics based?
Carmot Therapeutics is based in the United States.
Companies like Carmot Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.